FDA Hammers Drugmaker's 'Dangerous' Opioid Promos
The U.S. Food and Drug Administration's Office of Prescription Drug Promotion scolded AcelRx's marketing of a powerful opioid in a warning letter posted Tuesday, the first time this year the office...To view the full article, register now.
Already a subscriber? Click here to view full article